SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,665,628 | +9.8% | 21,990 | +3.8% | 0.00% | 0.0% |
| Q2 2023 | $2,427,252 | -16.2% | 21,195 | +0.8% | 0.00% | 0.0% |
| Q1 2023 | $2,898,151 | -4.4% | 21,027 | -10.2% | 0.00% | 0.0% |
| Q4 2022 | $3,032,949 | +37.7% | 23,406 | +17.5% | 0.00% | 0.0% |
| Q3 2022 | $2,202,000 | +37.3% | 19,914 | -6.9% | 0.00% | +100.0% |
| Q2 2022 | $1,604,000 | +17.6% | 21,395 | +22.6% | 0.00% | 0.0% |
| Q1 2022 | $1,364,000 | -18.7% | 17,454 | -6.3% | 0.00% | 0.0% |
| Q4 2021 | $1,677,000 | -23.8% | 18,626 | -21.7% | 0.00% | 0.0% |
| Q3 2021 | $2,201,000 | +5.7% | 23,799 | -11.1% | 0.00% | 0.0% |
| Q2 2021 | $2,082,000 | +4.0% | 26,782 | -0.2% | 0.00% | 0.0% |
| Q1 2021 | $2,001,000 | -53.7% | 26,845 | +6.0% | 0.00% | -66.7% |
| Q4 2020 | $4,320,000 | +22.4% | 25,337 | +0.8% | 0.00% | 0.0% |
| Q3 2020 | $3,529,000 | -19.2% | 25,128 | -7.8% | 0.00% | -25.0% |
| Q2 2020 | $4,368,000 | +129.7% | 27,241 | +40.1% | 0.00% | +100.0% |
| Q1 2020 | $1,902,000 | -21.0% | 19,438 | +4.1% | 0.00% | 0.0% |
| Q4 2019 | $2,409,000 | +70.2% | 18,675 | -0.5% | 0.00% | +100.0% |
| Q3 2019 | $1,415,000 | -56.8% | 18,777 | -12.9% | 0.00% | -66.7% |
| Q2 2019 | $3,275,000 | +35.8% | 21,560 | +6.5% | 0.00% | +50.0% |
| Q1 2019 | $2,411,000 | +27.7% | 20,240 | +17.0% | 0.00% | 0.0% |
| Q4 2018 | $1,888,000 | -39.4% | 17,302 | -10.4% | 0.00% | -33.3% |
| Q3 2018 | $3,118,000 | +27.3% | 19,305 | +4.2% | 0.00% | +50.0% |
| Q2 2018 | $2,449,000 | +65.7% | 18,528 | -7.1% | 0.00% | +100.0% |
| Q1 2018 | $1,478,000 | +36.9% | 19,946 | +2.7% | 0.00% | 0.0% |
| Q4 2017 | $1,080,000 | +168.7% | 19,416 | +118.8% | 0.00% | – |
| Q3 2017 | $402,000 | +29.7% | 8,873 | -3.5% | 0.00% | – |
| Q2 2017 | $310,000 | +10.7% | 9,199 | -2.7% | 0.00% | – |
| Q1 2017 | $280,000 | +9.4% | 9,455 | +1.4% | 0.00% | – |
| Q4 2016 | $256,000 | -45.2% | 9,326 | +22.6% | 0.00% | -100.0% |
| Q3 2016 | $467,000 | +56.7% | 7,606 | -1.5% | 0.00% | – |
| Q4 2015 | $298,000 | +32.4% | 7,722 | +10.1% | 0.00% | – |
| Q3 2015 | $225,000 | +35.5% | 7,016 | -38.9% | 0.00% | – |
| Q4 2014 | $166,000 | -34.1% | 11,479 | +35.8% | 0.00% | – |
| Q2 2014 | $252,000 | +0.8% | 8,454 | -18.6% | 0.00% | – |
| Q1 2014 | $250,000 | -46.8% | 10,384 | +4.4% | 0.00% | -100.0% |
| Q3 2013 | $470,000 | +16.6% | 9,948 | -6.2% | 0.00% | 0.0% |
| Q2 2013 | $403,000 | – | 10,601 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |